![](/images/graphics-bg.png)
Subcutaneous use of rapid insulin analog : an alternative treatment for atients with mild to moderate diabetic ketoacidosis
المؤلفون المشاركون
al-Hefnawy, H.
al-Ebrashy, I.
Basyouni, A.
Mahfouz, H.
المصدر
Egyptian Pediatric Association Gazette
العدد
المجلد 57، العدد 4 (31 أكتوبر/تشرين الأول 2009)، ص ص. 28-34، 7ص.
الناشر
تاريخ النشر
2009-10-31
دولة النشر
مصر
عدد الصفحات
7
التخصصات الرئيسية
الموضوعات
الملخص EN
Background: diabetic ketoacidosis (DKA) is a life-threatening condition that requires hospitalization in children with type 1 diabetes.
Many reports have indicated that low-dose insulin therapy is quite effective regardless of the route of administration, whether, intramuscular, or subcutaneous.
Aims : the aim of this study was to look for technical simplification and economic efficiency in the treatment of diabetic ketoacidosis (DKA) with subcutaneous use of the rapid-acting insulin analog and compare its use with regular intravenous insulin treatment.
Methods : A total of 80 consecutive patients admitted with DKA were randomly classified into 4 groups : Group 1: Patients with DKA on regular insulin by infusion pump, (infusion pump, n = 20), group 2 : patients with DKA on subcutaneous rapid onset of action-as part insulin analog (Novo log; Novo Nordisk) / 2 hrs, sc-2hr, n = 20), group 3: Patients with DKA on subcutaneous rapid onset of action-as part insulin analog (Novo log ; Novo Nordisk) / 1 hrs, (sc-lhr, n = 20), and group 4 : Patients with DKA on rapid insulin analog by continues subcutaneous insulin pump (CSII, n.= 20).
Results : the results of this study showed that there was no statistical difference between the 4 groups as regarding age in years, blood glucose in mg / dl before the starting of management of DKA, pH, serum HC03, serum K, anion gap, urine acetone and time needed for resolution of DKA by hours.
Conclusion : it could be concluded that management of any patient with mild to moderate DKA with good tissue perfusion can be treated with subcutaneous rapid insulin analog every 1 or 2 hours or to be treated by continuous insulin infusion pumps, if available with same results as giving regular insulin by intravenous infusion pumps.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
al-Ebrashy, I.& al-Hefnawy, H.& Basyouni, A.& Mahfouz, H.. 2009. Subcutaneous use of rapid insulin analog : an alternative treatment for atients with mild to moderate diabetic ketoacidosis. Egyptian Pediatric Association Gazette،Vol. 57, no. 4, pp.28-34.
https://search.emarefa.net/detail/BIM-249260
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
al-Ebrashy, I.…[et al.]. Subcutaneous use of rapid insulin analog : an alternative treatment for atients with mild to moderate diabetic ketoacidosis. Egyptian Pediatric Association Gazette Vol. 57, no. 4 (Oct. 2009), pp.28-34.
https://search.emarefa.net/detail/BIM-249260
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
al-Ebrashy, I.& al-Hefnawy, H.& Basyouni, A.& Mahfouz, H.. Subcutaneous use of rapid insulin analog : an alternative treatment for atients with mild to moderate diabetic ketoacidosis. Egyptian Pediatric Association Gazette. 2009. Vol. 57, no. 4, pp.28-34.
https://search.emarefa.net/detail/BIM-249260
نوع البيانات
مقالات
لغة النص
الإنجليزية
رقم السجل
BIM-249260
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)